Forum Replies Created
Thanks to Natire Portfolio for this piece.
Oops, forgot link!
See here –
GavinJuly 26, 2021 at 7:57 am in reply to: UK News NICE has approved Pemigatinib (Pemaryze) as first treatment for people w #101182
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Thanks to Elsevier Ltd for this piece.
Patients with rare bile duct cancer set to benefit from life extending treatment
GavinJuly 14, 2021 at 9:19 am in reply to: Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary #101161
Please see this link for further details of the trial etc.
GavinJuly 14, 2021 at 9:17 am in reply to: Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary #101160
Some more news from the Annual meeting –
Poster roundup link –
GavinFebruary 8, 2021 at 6:24 am in reply to: Effect of Tumor Size on Long-Term Survival After Resection for Solitary Intrahep #100818
Great to hear from you and see you on here as always. And what absolutely brilliant news you have to share with us all! Am sorry for just getting round to replying to your post now. 11 years is superb and no doubt Lainy would tell you to you go girl or something like that!
What a fighter you are and what you have had to go through is huge. And what you have done in these 11 years is amazing as well so big congrats to you as well. You even made it to Scotland as well, ha!!
Here’s hoping that 2021 will be a good year for you and for all of us as well. And who knows what you will achieve in the next 11 years!
Thank you Randi!
I am sorry to hear about your uncle. Yes there are some postings from the board members here regarding their experiences or that of their loved ones and Folfox here on the site. You will be able to search for them if you want to and read them by using the search forum function here on the discussion board. Just type in FOLFOX into the search box and it will throw up all the relevant discussions on that subject.
I hope that is helpful and I hope that someone will be along soon that can also possibly share personal experiences of it as well.
My best wishes to you,
GavinAugust 21, 2020 at 9:50 pm in reply to: Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc #100373
Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutationsAugust 18, 2020 at 10:11 pm in reply to: Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc #100364
Dabrafenib Plus Trametinib for Patients With BRAF V600E–Mutated Cholangiocarcinoma
https://ascopost.com/news/august-2020/dabrafenibtrametinib-for-patients-with-braf-v600e-mutated-cholangiocarcinoma/?email=0b78bf89ac8ef35ad4793e2385fe1c4fb5e909d4bb0ada7f211f6774dee92c4f&utm_medium=email&utm_source=TAPEN-Automated-US-Template&bc_md5=b50ee48c95ff9f6ae4ae9cd014d5ca9c#.XzxRyjW9rFc.twitterAugust 18, 2020 at 1:53 pm in reply to: Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc #100363
Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutationsJuly 2, 2020 at 8:55 am in reply to: FDA Approval Sought for Pralsetinib to Treat Advanced RET+ Thyroid Cancers #100246
Thanks for that Tarheelll.